Search for: "Mylan Pharmaceuticals"
Results 641 - 660
of 739
Sorted by Relevance
|
Sort by Date
4 May 2011, 7:52 am
Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms Fentanyl Fentanyl Extended Release Transdermal System Watson … [read post]
6 Aug 2011, 2:27 pm
Bodily Injury: COURT FINDS NO BODILY INJURY IN DEAD-BODIES CASE, Owners Ins. [read post]
1 Nov 2017, 2:58 pm
See also, 16-712bsacAAM; and 16-712 bsac America’s Health Insurance Plans; 16-712 bsac Mylan Pharmaceuticals Inc_ (“Mylan’s experiences with inter partes review highlight the pro-competitive nature of inter partes review. [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
5 Mar 2015, 5:52 am
Mylan Pharmaceutical, Inc., ___ F. [read post]
12 Mar 2017, 9:28 am
Amici briefs have been filed by Apotex, Coherus (see recent Kat post), Biosimilars Council and Mylan, all supporting Sandoz. [read post]
25 Jan 2017, 11:25 pm
However, claim 27 is to “a pharmaceutical composition comprising a compound according to any one of claims 1-25 together with a pharmaceutically acceptable carrier and optionally other therapeutic ingredients” (emphasis added). [read post]
9 Aug 2021, 2:22 pm
Scilex Pharmaceuticals Inc. v. [read post]
26 Aug 2015, 11:02 am
., Ltd. and licensed to Teva Pharmaceuticals Industries Ltd. [read post]
6 Nov 2014, 5:00 am
Mylan, Inc., 661 F. [read post]
11 Dec 2018, 4:55 am
Here’s an event for you | Public procurement of pharmaceuticals and the patent system, the first date of a stormy relationship? [read post]
1 Feb 2016, 10:43 am
The CAFC affirmed SDNY in the oxycontin case:For the foregoing reasons, we affirm the district court’s invalidity determinations as to the low-ABUK patents and the ’383 patent and the district court’s dis-missal of the Epic, Mylan, and Amneal actions. [read post]
20 May 2013, 11:52 pm
Mylan concerning fexofenadine.The decision is by a 2-1 vote.The initial part of the decision:Aventis Pharmaceuticals, Inc. and Albany MolecularResearch, Inc. [read post]
31 Jan 2014, 7:26 am
Mylan, Inc., No. 12-2502, 2013 U.S. [read post]
8 Feb 2017, 3:09 am
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
14 Nov 2016, 9:16 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
3 Jun 2016, 6:40 am
., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
16 Jan 2017, 5:44 pm
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
13 Oct 2016, 6:50 am
Lee, No. 16-446 (Eligibility of new use of old manufacture – blackjack game) Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
11 Mar 2019, 7:08 pm
The asymmetry of this burden is especially salient in domains like pharmaceutical drugs and biosimilars, where the incentive to test the validity of patents has important social consequences, and the complexities of those decades-long disputes create fact patterns that can be difficult to unpack. [read post]
